Author:
Kim Michelle M.,Parmar Hemant,Cao Yue,Pramanik Priyanka,Schipper Matthew,Hayman James,Junck Larry,Mammoser Aaron,Heth Jason,Carter Corey A.,Oronsky Arnold,Knox Susan J.,Caroen Scott,Oronsky Bryan,Scicinski Jan,Lawrence Theodore S.,Lao Christopher D.
Reference37 articles.
1. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma;Sampson;J Neurosurg,1998
2. Determinants of outcome in melanoma patients with cerebral metastases;Fife;J Clin Oncol,2004
3. Prognostic factors for survival in melanoma patients with brain metastases;Davies;Cancer,2011
4. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial;Margolin;Lancet Oncol,2012
5. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicenter, open-label, phase 2 trial;Long;Lancet Oncol,2012
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献